INTRODUCTION
During embryogenesis, paired pharyngeal arch arteries (PAAs) form symmetrically relative to the embryonic midline, connecting the heart with the dorsal aortae. In birds and mammals, the first and second PAAs regress, whereas the PAAs 3, 4 and 6 undergo asymmetric remodeling giving rise to the aortic arch arteries (AAAs) (Hutson and Kirby, 2007; Olson, 2002) . Defects in PAA development are common features of congenital heart disease, warranting further detailed investigation into cellular and molecular mechanisms regulating their formation.
The argument of whether or not mammalian PAAs arise by angiogenesis or by vasculogenesis dates back to the early 1900s (Congdon, 1922) . Investigations of human, rabbit, chicken and mouse embryos demonstrated the presence of endothelial plexus in the pharyngeal region prior to the appearance of PAA lumens, and it was hypothesized that this vascular plexus gave rise to the PAAs (Bremer, 1912; Congdon, 1922; DeRuiter et al., 1993a; DeRuiter et al., 1993b; DeRuiter et al., 1992; Li et al., 2012; Waldo et al., 1996) . However, the origin of the endothelial cells in the plexus and subsequently, in the PAAs has remained unknown. Resin filling of embryonic vasculature demonstrated the presence of small vascular branches connected to the dorsal aortae and the aortic sac at early stages of PAA formation, suggesting that the PAA endothelium arose by branching off from these vessels (Hiruma et al., 2002) . In contrast, recent studies using genetic labeling and the Tie2-Cre transgenic mice ruled out the dorsal aorta as the source of the PAA endothelium (Li et al., 2012) . Understanding the origin of endothelial progenitors giving rise to the PAAs is imperative for elucidating the mechanisms regulating PAA formation and alterations that lead to congenital heart disease.
Broadly, the anterior mesoderm, which includes the PAA endothelium arises from Mesp1-expressing progenitors during early gastrulation (Liang et al., 2014; Papangeli and Scambler, 2013) . It is also known that a small proportion of the PAA endothelium expresses Nkx2.5 or derives from Nkx2.5-expressing progenitors (Paffett-Lugassy et al., 2013) . However, a precise embryonic tissue that gives rise to the PAA endothelium in mice is unknown. It is also not known how endothelial progenitors are recruited into the pharyngeal arches and the mechanisms regulating the formation of PAA lumens.
In the studies described below, we determined that the PAA endothelium in the pharyngeal arches 3 -6 arises from a subset of the splanchnic mesoderm within the Mesp1 lineage. This subset is defined by the expression of the Isl1 transcription factor and the Mef2C-AHF-Cre demonstrate that cells within the SHF express VEGFR2, delaminate from the SHF, migrate into the pharyngeal mesenchyme, and form a plexus of small blood vessels, which then remodels into the PAA in each arch.
Mutations in Tbx1, Gbx2, PlexinD1 and Fgf8 interfere with PAA formation (Calmont et al., 2009; Gitler et al., 2004; Jerome and Papaioannou, 2001; Lindsay et al., 2001; Macatee et al., 2003; Merscher et al., 2001 ); However, which particular stages of PAA formation are regulated by these genes is unknown. Identification of PAA endothelial progenitors and cellular mechanisms regulating PAA formation are important steps toward understanding the etiology of congenital heart disease.
MATERIALS AND METHODS

Mouse strains
Cdh5(PAC)-CreERT2 transgenic mice were a gift from Dr. Ralph Adams (Wang et al., 2010) . Rosa mTmG mice, Gt(ROSA)26Sortm4(ACTB-tdTomato-EGFP) generated by (Muzumdar et al., 2007) were purchased from Jackson Labs (stock number 007676). Tg(Mef2c-cre)2Blk/Mmnc strain, also known as the Mef2C-AHF-Cre transgenic mice (Verzi et al., 2005) were obtained from the Mutant Mouse Resource and Research Center (stock number 030262-UNC). The Isl1 Cre strain was a gift from Sylvia Evans (Cai et al., 2003) . All experimental procedures were approved by the Institutional Animal Care and Use Committee of Thomas Jefferson University and conducted in accordance with federal guidelines for humane care of animals.
Tracing endothelial lineage in pharyngeal arches
Tamoxifen solution (20 mg/ml) was prepared by dissolving Tamoxifen (Sigma, #T5648) in corn oil. The solution was heated at 40°C and rocked at 1000 rpm using Eppendorf Thermomixer® for 3 hours; insoluble particles were removed by centrifugation. To label endothelial cells with GFP prior to the formation of the PAAs 3 -6, we crossed ROSA mTmG females with Cdh5(PAC)-CreERT2 transgenic males, and injected 4 mg of tamoxifen per 25g of body weight, into pregnant females in the morning (10-11am) of day E7.5. Embryos were dissected in the morning of day E9.5, and were subjected to whole mount staining with the antibodies against GFP (1:500, Aves labs, #GFP-1020) and VEGFR2 (1:200, R&D, #AF644). Nuclei were stained with DRAQ5. Stained embryos were then imaged using Olympus FV500 confocal microscope. Three-dimensional (3D) reconstructions and surface renderings were performed using Imaris (Bitplane, USA).
Whole-mount immunofluorescence staining and confocal image acquisition
Embryos at E9.5 or E10.5 were dissected and fixed at 4°C in 4% paraformadehyde overnight for ~ 15 hours with gentle rocking. Embryos were then rinsed and washed with PBS every 30 min for 1 to 2 hours. The number of somites (s) was counted in each embryo analyzed. Prior to staining, the head, forelimb buds and trunk posterior to the forelimb buds in E10.5 embryos were trimmed off. E9.5 embryos and younger were used without trimming. During all incubations, embryos were kept in 2 ml eppendorf tubes (Fisherbrand, , with 1 embryo per tube. Embryos were first incubated in 500 μl of blocking buffer (PBS with 0.1% Triton X100 and 10% Donkey serum) overnight at 4°C with gentle rocking, then with 450 μl of blocking buffer containing 1° antibodies for 72 hours at 4°C, with gentle rocking. The following 1° antibodies were used: anti-PECAM1 (BD Pharmingen, #553370, 1:200), anti-VEGFR2 (R&D, AF644, 1:200), anti-ERG (Abcam, ab110639, 1:100), and anti-GFP (Aves lab, #GFP1020, 1:500). After the incubation with 1° antibodies, embryos were rinsed and washed every hour with PBST (PBS with 0.1% Triton X100) for at least 5 hours. Embryos were then incubated with 450 μl of 2° antibodies diluted 1:300 in blocking buffer for 48 hours at 4°C. Alexa-labeled 2° antibodies were purchased from Invitrogen. FITC conjugated anti-chicken IgY antibodies were from Jackson Immunoresearch, #703-546-155. After staining with 2° antibodies, embryos were washed as above, and incubated with DRAQ5 (1:500 dilution in PBST, Cell signaling technology, #4048) for 48 hours to stain nuclei. This extra incubation step was necessary because the presence of serum in the blocking buffer interferes with DRAQ5 staining. Prior to imaging, embryos were dehydrated in 50% methanol in PBS for 5 minutes, followed by 100% methanol two times for 5 minutes each, and cleared in BABB generated by mixing benzyl alcohol (Sigma, #B1042) and benzyl benzoate (Sigma, #B6630) at 1:2 (v/v). This procedure eliminates the native GFP and tdTomato fluorescence from ROSA mTmG mice, allowing the use of any combination of the fluorophores described above. Images of entire pharyngeal arches were acquired with Olympus FV500 confocal microscope, collecting optical sections every 0.62 μm through the entire thickness of the embryo.
3D quantitative analyses of confocal images
Overall, we analyzed 6 pharyngeal arches from embryos having 30 -31 somites (s), 16 pharyngeal arches from embryos having 33 -34 s, and 10 pharyngeal arches from embryos with 36 -39 s. 3D image reconstruction and analyses of cell numbers and distributions were performed using Imaris, and the methodology is illustrated in Sup. Figs. 1 -2. To label and quantify the number of endothelial cells in the PAA and plexus of the 4 th arch, we used the surface function in Imaris to create a segment encompassing the 4 th pharyngeal arch, excluding all other regions (Sup. Fig. 1A -C) . We then generated a new channel encompassing all of the endothelial cells within this segment (Sup. Fig. 1D , region in red). To separate the PAA endothelium from the plexus, we segmented the pharyngeal arch artery endothelium as shown in Sup. Fig. 1F -G and generated a new surface containing Pecam1 + cells within the PAA (Sup. Fig. 1H ). We then generated a new channel containing endothelial cells in the PAA (Sup. Fig. 1I , PAA). The channel with plexus endothelial cells was generated by excluding endothelial cells in the PAA (Sup. Fig. 1J ). To quantify the number of endothelial cells, ERG + nuclei within these channels were counted using the Spots function in Imaris, as illustrated in Sup. Fig. 2 . This number was confirmed by manual counting in several samples.
The number of SHF-derived endothelial cells in each PAA was quantified in 4 E10.5 embryos, ranging from 33s to 35s, 2 of these embryos were from the Isl1 Cre ; Rosa mTmG strain and the other 2 embryos were from the Mef2C-AHF-Cre; Rosa mTmG strain. All embryos were stained with antibodies to GFP, VEGFR2 and ERG, and pharyngeal arches were imaged using confocal microscopy, collecting optical sections through the entire thickness of the embryo, sampling every 0.62 μm. The number of GFP + and GFP − endothelial cells in each pharyngeal arch was determined in optical sections spaced 15 -20 microns, using the Imaris software. A total of 707 endothelial cells were examined in the 3 rd PAAs, 589 endothelial cells were analyzed in the 4 th PAAs, and 370 endothelial cells were analyzed in the 6 th PAAs. The results of these analyses were plotted in Fig. 2B‴ , and statistical significance was determined using 2-way ANOVA and the GraphPad Prism 6 software.
Staining of tissue sections
For frozen sections, fixed embryos were rinsed in PBS and incubated in 30% sucrose solution prepared in PBS until embryos sunk to the bottom of the tube. This was followed by incubation in 50/50 mix of 30% sucrose solution and optimum cutting temperature (OCT) compound (Tissue-Tek) at 4°C overnight. Embryos were then embedded in OCT and frozen using an isopentane/dry ice bath. The following primary antibodies were diluted in blocking buffer (10% donkey serum, PBS, 0.05% Tween-20) and used to stain frozen sections overnight at 4°C: anti-VEGFR2 (1:200, R&D, #AF644), anti-ERG (1:100, Abcam, #ab110639), anti-GFP (1:500, Aves labs, #GFP-1020), and anti-Cre (1:500, Millipore, #MAB3120). Slides were washed in PBS containing 0.05% Tween 20 (PBS-Tween) with three changes of washing buffer, 10 min each, and then incubated with Alexa-conjugated 2° antibodies, diluted 1:300 in blocking buffer for 2 hours at room temperature. After washing in PBS-Tween, sections were mounted using a 1:1 mixture of methanol and glycerol (v/v) to extinguish the native GFP and tdTomato fluorescence. Slides were imaged using Olympus FV500 confocal microscope. Each experiment was repeated at least three times, using 3 independent embryos.
Cell proliferation
5 mg/ml BrdU solution was prepared by dissolving BrdU (Fisher Scientific, # BP2508250) in PBS. BrdU (30mg per kg of body weight) was injected intraperitoneally into pregnant females 30 minutes before they were sacrificed. 66 sections from 10 pharyngeal arches (5 right and 5 left) were analyzed. Paraffin sections were stained with anti-ERG and anti-BrdU antibodies (Abcam, #ab6326, 1:100) after antigen retrieval with 10 mM citric acid buffer, pH 6.0. Alexa-labeled secondary antibodies were used to detect the bound 1° antibodies, and nuclei were visualized using DRAQ5.
Cell survival
Anti-cleaved caspase-3 antibody (1:100, Cell Signaling Technology, #9661) was used to detect apoptosis in whole embryos (5 embryos were analyzed using whole-mount staining followed by confocal scanning, and an additional 3 embryos were sectioned to perform the TUNEL assay). Whole mount immunofluorescence staining and imaging were performed as described above. In Situ Cell Death Detection Kit, Fluorescein TUNEL was purchased from Roche (#11684795910). TUNEL labeling was performed using cryosections according to the manufacturer's instructions.
RESULTS AND DISCUSSION
Endothelium of the PAAs 3 -6 is not derived from the dorsal aorta, endocardium, or the aortic sac
By 18 somites (s) of mouse development, pharyngeal endothelial cells are present as a uniform plexus within the region corresponding with the future arches 3 -6 (Li et al., 2012) . To determine whether the endothelium in these pharyngeal arches arose from the dorsal aorta, the aortic sac, or the endocardium, we performed transient lineage labeling studies with the aim of labeling the endocardium and endothelium prior to the formation of the PAAs 3 -6. If pharyngeal endothelial cells were derived from the dorsal aorta, aortic sac, endocardium, or from an earlier progenitor in common with these vascular beds, they would express GFP due to the presence of the ROSA mTmG reporter. For these experiments, ROSA mTmG females were crossed with Cdh5(PAC)-CreERT2 transgenic males, in which the expression of tamoxifen-inducible Cre recombinase in the endothelium is driven by the Cdh5 regulatory elements (Wang et al., 2010) . Pregnant females were injected with tamoxifen at E7.5. The half-life of tamoxifen in serum is ~12 hours (Robinson et al., 1991) , and Cre-mediated expression of a reporter becomes detectable in 95% of cells within the first 24 hours after injection (Hayashi and McMahon, 2002) . Thus, the injection of tamoxifen at E7.5 allows labeling of blood vessels formed by E8.5. These vessels include the endothelium of the dorsal aortae, the aortic sac, the ventral aortae (discussed in more details below), and the endocardium; but not the pharyngeal arteries 3 -6, which are not present at that time.
We dissected labeled embryos at E9.0, 48 hours after the injection of tamoxifen, and performed whole mount confocal immunofluorescence microscopy followed by 3D image reconstruction. In these and all other imaging experiments, we inactivated the native GFP and tdTomato fluorescence by clearing embryos with methanol and BABB (see Methods). Endothelial cells were visualized using anti-VEGFR2 antibody, GFP was detected using anti-GFP antibody, and nuclei using DRAQ5. Confocal imaging of whole embryos shows that the injection of tamoxifen at E7.5 leads to the expression of GFP in the endocardium of the heart (h in Fig. 1A -C, 1I ), in the dorsal aorta (da in Fig. 1D-H2 , J -J2 ), and in the aortic sac (Fig. 2I and Sup. Movie 1). The endothelium of the ventral aortae is also GFP + (Fig. 1I -H2 , see further discussion of the ventral aortae in Section 3.3). Interestingly, the majority of endothelial cells in the pharyngeal region corresponding with the future arches 3, 4 and 6 are GFP − (see the region circumscribed by the dashed line in Fig. 1D -F and surface-rendered in Fig. 1G ). In contrast, the endothelium of the 1 st and 2 nd PAAs and that of intersomitic arteries are GFP + (Fig. 1A -C, Sup. Movie 1). Intersomitic arteries arise from the dorsal aorta by angiogenesis (Coultas et al., 2005) . Thus, the labeling of the 1 st and 2 nd PAAs and the intersomitic arteries with GFP serves as the internal positive control for vessels that either arose from the dorsal aorta or have progenitors in common with the dorsal aorta. Alternatively, as is the case with the 1 st and 2 nd PAAs, the GFP labeling of these PAAs occurred because these vessels/endothelial cells were present contemporaneously with the injected tamoxifen.
Even though tamoxifen mediated extensive labeling of the dorsal and ventral aortae, the endocardium, the aortic sac endothelium, and the endothelium in the 1 st and 2 nd pharyngeal arches in Cdh5(PAC)-CreERT2 transgenic embryos, endothelial cells in the pharyngeal arches 3 -6 lacked GFP labeling (Fig. 1A -F and 1H1 -H2 ). The only GFP + cell seen in this region (Fig. 1D -G) is derived from the common cardinal vein (Fig. 1F, Sup. Fig. 3 , and Sup. Movie 2). Nearly all, 95 of 102, endothelial cells in the dorsal aorta were GFP + (transverse and sagittal optical slices in Fig. 1H1 -J2) . Similarly, nearly all endothelial cells in the heart, the aortic sac and the ventral aortae were also GFP + (Fig. 1I, 1H1 -H2 and Sup. Movie 1, showing all sagittal optical sections through the embryo). The absence of GFP + cells in the endothelium within the pharyngeal arch region 3 -6 (with the exception of one GFP + cell) suggests that the pharyngeal endothelium in arches 3 -6 is derived from a source other than the dorsal aortae, the aortic sac, the ventral aortae or the endocardium.
PAA endothelial cells arise from the second heart field
The high dose of tamoxifen used in the experiments described above was necessary to achieve efficient cell labeling; however, its toxicity precluded examination of embryos at later time points. To complement these experiments and to identify the major source of endothelial cells in the PAAs 3 -6, we used lineage tracing. Our earlier studies and the work of others showed that the majority of PAA endothelial cells in mice are derived from Mesp1 + precursors (Liang et al., 2014; Papangeli and Scambler, 2013) . We also found that the majority of PAA endothelial cells express Isl1 in embryos older than 36s (Chen et al., 2015) , suggesting that PAA endothelial cells could have been derived from the second heart field (SHF) mesoderm. However, the expression of the Isl1 protein in the PAA endothelium does not indicate lineage. To determine whether precursors of the PAA endothelium originate in the SHF, we analyzed embryos from the Mef2C-AHF-Cre transgenic mice at different stages of development (Verzi et al., 2005) . The Mef2C-AHF enhancer drives the expression of Cre exclusively in the SHF (Dodou et al., 2004; Verzi et al., 2005) . Examination of GFP + cells within the SHF in Mef2C-AHF-Cre; Rosa mTmG embryos at 24s demonstrated that many SHF cells express VEGFR2 ( Fig. 2A -A″) , extend cellular processes toward the gut endoderm, and appear to be emigrating from the SHF and joining with the pharyngeal endothelial plexus (arrowheads in 2A″). Patent PAAs 3 -6 are formed by E10.5 (≥33s), and at this time, the majority of endothelial cells in the PAAs 3 -6 are GFP + (Fig. 2B -B‴) . To determine whether GFP + cells in the PAAs 3 -6 were related to the SHF by lineage, we stained sections with antibodies against the Cre recombinase. Although Cre is expressed in the SHF (arrowheads and red signal in Fig. 2B, B″) , it is not expressed in the majority of the GFP + PAA endothelium (Fig. 2B′ -B″) , indicating that the expression of GFP in the PAA endothelium represents a true fate map. In contrast, endothelial cells in the first and second pharyngeal arches were mostly GFP − in Mef2C-AHF-Cre; Rosa mTmG embryos, while the mesodermal core of these arches was GFP + (see Figs. 2C -C″, 2C1 -2C1″ for E10.5 embryos and Fig. 4A -B″ for E9.5 embryos). This is consistent with the labeling experiments in Fig. 1 , and supports the notion that the endothelium in the pharyngeal arches 1 and 2 arose earlier and is of different origin than the endothelium in the PAAs 3 -6.
Quantitatively, SHF contributes to 90+/−10% of endothelial cells in the 3 rd PAAs, 95+/−5% of endothelial cells in the 4 th PAAs, and 91+/−11% of endothelial cells in the 6 th PAAs at E10.5 (Fig. 2B‴) . The contribution of SHF-derived cells to the left PAAs 3 -6 was slightly higher than to the right PAAs (Fig. 2B‴, p=0 .03, 2-way ANOVA).
Symmetrical PAAs become remodeled into the AAAs by E13.5. To determine whether the AAAs retain the SHF-derived endothelium, we analyzed transverse and coronal sections through Mef2C-AHF-Cre;ROSA mTmG embryos isolated at E15.5 and E16.6. We found that indeed, the endothelium of the carotid arteries, which are derived from the left and right 3 rd PAAs is GFP + (Fig. 2D, rCA, lCA) . Similarly, endothelial cells of the ductus arteriosus, which is derived from the left 6 th PAA (Fig. 2E ) and endothelial cells of the aortic arch, which is derived from the left 4 th PAA are GFP + (Fig. 2F -F″) . The short proximal portion of the right subclavian artery is derived from the right 4 th PAA, and have not been analyzed here. The right 6 th PAA completely degenerates during the remodeling of the PAAs into the AAAs. Together, these experiments demonstrate that the AAA endothelium is mainly composed of SHF-derived cells.
SHF progenitors giving rise to the aortic sac and the PAAs are temporally and spatially distinct
The aorta and the pulmonary trunk arise from the OFT and the aortic sac, which connects the OFT with the PAAs (Waldo et al., 2005a; Waldo et al., 1996) . Fate mapping studies show that the endothelium of the OFT and the aortic sac is derived from the SHF (Cai et al., 2003; Sun et al., 2007; Verzi et al., 2005) . The endothelium of the aorta and pulmonary trunk is also derived from the SHF (Fig. 2F -F″) . Despite the fact that the endothelium of the OFT and the PAAs 3 -6 is SHF-derived, morphological and fate-mapping data discussed below argue that the aortic sac does not give rise to the PAA endothelium. To see this, we first need to consider endothelial components in the developing pharyngeal region, which were first described over a century ago by John Lewis Bremer (Bremer, 1912 ).
Bremer noted the presence of two vessels on either side of the midline, located dorsal to the OFT, and running along the embryo's anterior-posterior axis (Bremer, 1912) . These vessels, which Bremer referred to as the ventral aortae, connect the arterial pole of the heart with the nascent 1 st and 2 nd PAAs anteriorly and with the developing PAAs 3 -6 th posteriorly (Bremer, 1912) . Using Imaris and confocal immunofluorescence microscopy of Mef2C-AHF-Cre;ROSA mTmG embryos labeled with antibodies to VEGFR2 and GFP, we generated a 3D reconstruction of the ventral aortae extending posteriorly from the heart of the 25-somite mouse embryo (E9.5) (Fig. 3A -A′) . The region encompassing the ventral aortae (marked by arrows in Fig. 3A -A′) becomes incorporated into the OFT, as shown by dye injection experiments in chick (Waldo et al., 2005a; Waldo et al., 2005b; Waldo et al., 2001) . Sagittal sections through the ventral aorta of Mef2C-AHF-Cre;ROSA mTmG embryos show that the endothelium of the ventral aorta is connected with the OFT anteriorly and expresses GFP (Fig. 3A″) . The ventral aortae extending posteriorly from the OFT are lumenized prior to the formation of patent 3 rd , 4 th and 6 th PAAs (Fig. 1H1, H2 and transverse sections in Fig.  3 ). By 33s, the ventral aorta on each side of the midline is connected with the PAAs (Fig. 3B1 -B3 ) and gives rise to the aortic sac connecting all the posterior PAAs with the OFT by 35s (Fig. 3C -C′) .
Several lines of evidence indicate that PAAs do not arise from the ventral aortae or the aortic sac: 1) The aortic sac and ventral aortae are extensively labeled with GFP in Cdh5(PAC)-CreERT2;ROSA mTmG transgenic embryos upon the injection of tamoxifen at E7.5 (short straight arrows in Fig. 1I, H1 -H2) , while endothelial cells in the future pharyngeal arches 3 -6 are not labeled (Fig. 1A-G, H1 -H2 ) ; This indicates that the endothelium of the pharyngeal arch arteries arises later than that of the aortic sac/ventral aortae; 2) The ventral aortae are connected with the OFT and are lumenized before they form connections with the endothelial plexus of the future PAAs 3 -6 (Fig. 1I, H1 -H2 and transverse level ii in Fig.  3) . Finally, the paired ventral aortae form medially, while the PAA endothelium forms laterally relative to the midline (Fig. 1H1 -2, Fig. 3A′ , A″ and transverse sections in Fig.  3 ). In summary, these data show that SHF-derived progenitors giving rise to the endothelium of the ventral aortae and the aortic sac are spatially and temporally distinct from the SHF progenitors that give rise to the PAA endothelium in the pharyngeal arches 3 -6. Together with the studies demonstrating early separation of the myocardial and endothelial lineages in the heart, our work suggests that the SHF consists of several populations of progenitor cells, that are temporally and/or spatially distinct (Devine et al., 2014; Jain et al., 2015; MilgromHoffman et al., 2011) . Some of these progenitors give rise to the myocardium, while others give rise to the endothelial cells of the OFT, ventral aortae, aortic sac and the PAAs.
Connections of the PAAs with the dorsal aorta
At E9.0, when the connections between the pharyngeal plexus endothelium and the dorsal aortae are minimal, we find that there is only a small number of GFP + cells in the dorsal aorta of Mef2C-AHF-Cre; Rosa mTmG embryos (Fig. 4A, A″, arrowheads) . These GFP + cells are located at sites, where the dorsal aorta fuses with the pharyngeal endothelial plexus (Fig.  4B -B″, arrow) . At E10.5, when the connections between the PAAs with the dorsal aortae are well-formed, we observe extensive GFP labeling of the the dorsal aortae adjacent to the PAAs (Fig. 4C -C″, arrows) and increased numbers of GFP − endothelial cells in the portions of the PAAs proximal to the junctions of the PAAs with the dorsal aortae (Fig. 4D -D″, arrowhead). We hypothesize that GFP − cells at the PAA -dorsal aorta junctions migrate from the dorsal aorta to join with the PAA endothelium, and vice versa, that GFP + cells at the ventral surface of the dorsal aorta arise from the PAA endothelium. This hypothesis is consistent with the observation that endothelial cells are highly motile, and that they can move within and between blood vessels (Culver and Dickinson, 2010; Lucitti et al., 2007; Sato et al., 2010) .
PAAs form by the coalescence of the pharyngeal arch endothelium
Our studies demonstrated that pharyngeal plexus endothelium is derived from the SHF, as is the PAA endothelium (Figs. 2, 4) . This indicates that the PAAs arise by remodeling the pharyngeal endothelial plexus, as was proposed by earlier studies (Bremer, 1912; Congdon, 1922; DeRuiter et al., 1993a; DeRuiter et al., 1993b; DeRuiter et al., 1992; Li et al., 2012; Waldo et al., 1996) . To further understand the cellular mechanisms regulating PAA formation, we focused on the 4 th pair of PAAs, and used whole-mount confocal immunofluorescence microscopy to image these PAAs in carefully staged embryos (for the details about surface rendering and quantification methods see Sup. Figs. 1 -2) . At 30s -31s, in the morning of E10.5, the endothelium in the pharyngeal region corresponding with the arches 4 and 6 is assembled into a uniform, non-hierarchical plexus of blood vessels (Fig. 5A -B) . This plexus starts to rearrange between 30s and 34s, such that a nascent, thin PAA is seen by the 33 rd somite stage in the 4 th pharyngeal arch (Fig. 5C -D) . The 4 th PAA grows with time ( Fig. 5E -F) and is visibly in larger diameter than the surrounding endothelial plexus (Fig. 5D -F) . By the evening of E10.5, when embryos reach 36s -39s, a prominent, large PAA is seen in the 4 th pharyngeal arch (Fig. 5G -H) .
We found that the number of endothelial cells in the 4 th pharyngeal arch increases more than 2-fold between 30s and 39s (Fig. 5I) . As the 4 th PAA grows in diameter and length, the proportion of endothelial cells in the PAA increases, while the proportion of endothelial cells in the plexus decreases (Fig. 5J) : at 30s -31s, all endothelial cells in the 4 th arch are in the plexus of interconnected small vessels; at 33s -34s, endothelial cells are distributed equally between the PAA and the plexus; and at 36s-39s, 57% of endothelial cells are in the PAA and 43% in the plexus, p=2×10 −4 . Apoptosis is minimal in the pharyngeal endothelium of the 4 th arch at this time (Fig. 6 ). Despite the decrease in the fraction of plexus endothelium in the pharyngeal arch (Fig. 5J, pink line) , the proliferation index of plexus endothelial cells is ~2-fold higher than that of PAA endothelial cells, p<10 −4 (compare pink and green bars in Fig. 5K ). These analyses suggest that the 4 th pair of PAAs grows both by proliferation and by the acquisition of endothelial cells from the plexus. Indeed, sagittal sections show that the plexus endothelium is connected with the growing PAA (arrowheads in Fig. 5D, F, H) .
Understanding genes and mechanisms regulating the formation of the 4 th PAA is of particular clinical relevance, since aberrant formation of the left 4 th PAA gives rise to the interruption of the aortic arch type B, a lethal congenital defect. While a number of genes are already known to regulate the formation of the 4 th pair of PAAs, how they do so is not clear. Identification of the progenitors of PAA endothelium in the 4 th pharyngeal arches, their embryonic origin, and cellular dynamics regulating PAA formation are significant advances in the understanding of developmental processes regulating PAA formation. Our works shows that PAA formation could be regulated at a number of distinct steps, which include differentiation, proliferation, and survival of VEGFR2 + PAA progenitors in the SHF; exit and migration of these progenitors from the SHF into the pharyngeal mesenchyme; formation of endothelial plexus, and the coalescence of the pharyngeal plexus endothelium into the large PAA in each pharyngeal arch. Thus, our studies establish a platform for elucidating physiological mechanisms regulating PAA formation and for analyzing mutants that interfere with this process.
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Highlights
•
Endothelium in pharyngeal arches 3 -6 arises from the second heart field Embryos at different somite stages were stained to detect Pecam1 and imaged by confocal immunofluorescence microscopy. A, C, E, G. 3D reconstructions (maximum intensity projections) of pharyngeal vasculature; one side of each embryo is shown in each panel. Pharyngeal arches are numbered, da -dorsal aorta. Endothelium in the 4 th pharyngeal arch shown in A, C, E, and G was surface rendered in A′, C′, E′, and G′ (see Methods and Sup. Fig. 1 ). Sagittal optical sections through the embryos in A, C, E, and G are shown in B, D, F, and H. A, A′, B. Only uniform endothelial plexus is present in the 4 th arch at 30s-31s; it is surface rendered in pink in A′ and underlined by a bracket in B. C -F. A slightly younger (C -D) and a slightly older (E -F) embryo with 33-34s are shown. A thin 4 th PAA is visible at 33 -34s. The PAA is surface rendered in green and the plexus is surface rendered in pink in C′ and E′. Optical sagittal sections in D and F show the plexus endothelium (open arrowheads) connecting with the PAA. G -H. In the evening of E10.5, the 4 th PAA is nearly completely formed (G), surface rendered green in G′. It has a large lumen (H) and fewer endothelial cells in the plexus than at 33-34s, rendered in pink in G′; arrowhead in H. Arrows point to the dorsal aorta. I. Growth of endothelial population in the 4 th pharyngeal arch. J. As the 4 th PAA grows in size, the proportion of endothelial cells in the PAA increases (green line), while the proportion of endothelial cells in the plexus decreases (pink line). K. Proliferation index of plexus endothelial cells is nearly 2-fold higher than in the PAA. Box plots with all data points are shown, error bars span the minimum to maximum values. The box contains 50% of the data points and the horizontal bar inside the box marks the median. Unpaired, 2-tailed Student's t test was used to calculate p values. All scale bars are 100 μm.
